[go: up one dir, main page]

GB0711226D0 - Assay method - Google Patents

Assay method

Info

Publication number
GB0711226D0
GB0711226D0 GB0711226A GB0711226A GB0711226D0 GB 0711226 D0 GB0711226 D0 GB 0711226D0 GB 0711226 A GB0711226 A GB 0711226A GB 0711226 A GB0711226 A GB 0711226A GB 0711226 D0 GB0711226 D0 GB 0711226D0
Authority
GB
United Kingdom
Prior art keywords
assay method
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0711226A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fusion Antibodies Ltd
Original Assignee
Fusion Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fusion Antibodies Ltd filed Critical Fusion Antibodies Ltd
Priority to GB0711226A priority Critical patent/GB0711226D0/en
Publication of GB0711226D0 publication Critical patent/GB0711226D0/en
Priority to PCT/GB2007/050623 priority patent/WO2008044068A2/en
Priority to EP07824835A priority patent/EP2087113A2/en
Priority to AU2007306139A priority patent/AU2007306139B2/en
Priority to CA002683109A priority patent/CA2683109A1/en
Priority to NZ576119A priority patent/NZ576119A/en
Priority to US12/445,109 priority patent/US20100111965A1/en
Priority to JP2009531923A priority patent/JP5919593B2/en
Ceased legal-status Critical Current

Links

GB0711226A 2006-10-11 2007-06-09 Assay method Ceased GB0711226D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0711226A GB0711226D0 (en) 2007-06-09 2007-06-09 Assay method
PCT/GB2007/050623 WO2008044068A2 (en) 2006-10-11 2007-10-11 Combination therapy
EP07824835A EP2087113A2 (en) 2006-10-11 2007-10-11 Combination therapy
AU2007306139A AU2007306139B2 (en) 2006-10-11 2007-10-11 Combination therapy
CA002683109A CA2683109A1 (en) 2006-10-11 2007-10-11 Combination therapy
NZ576119A NZ576119A (en) 2006-10-11 2007-10-11 Combination therapy involving egf inhibitors
US12/445,109 US20100111965A1 (en) 2006-10-11 2007-10-11 Combination therapy
JP2009531923A JP5919593B2 (en) 2006-10-11 2007-10-11 Combination therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0711226A GB0711226D0 (en) 2007-06-09 2007-06-09 Assay method

Publications (1)

Publication Number Publication Date
GB0711226D0 true GB0711226D0 (en) 2007-07-18

Family

ID=38319139

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0711226A Ceased GB0711226D0 (en) 2006-10-11 2007-06-09 Assay method

Country Status (1)

Country Link
GB (1) GB0711226D0 (en)

Similar Documents

Publication Publication Date Title
IL194892A0 (en) Nonseparation assay methods
PL2021778T3 (en) Nonseparation assay methods
EP2171169A4 (en) Method
GB0713930D0 (en) Novel assay methods
IL196268A0 (en) Assay methods
GB0703366D0 (en) Method
GB0811567D0 (en) Assay
GB0807534D0 (en) Assay
GB0803850D0 (en) Assay
GB0811858D0 (en) Assay
GB0809262D0 (en) Assay
GB0705321D0 (en) Method
GB0814591D0 (en) Assay
GB0720672D0 (en) Assay method
GB0822260D0 (en) Assay
GB0822261D0 (en) Assay
GB0822010D0 (en) Assay
GB0821624D0 (en) Assay
GB0706833D0 (en) Method
EP2231868A4 (en) Assay method
GB0819405D0 (en) Assay method
GB0716915D0 (en) Assay method
GB0711226D0 (en) Assay method
GB0823657D0 (en) Assay Method
GB0604682D0 (en) Assay Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)